Bright Uro Strengthens Leadership with New Appointments
In a significant move to enhance its leadership team, Bright Uro, a pioneering medical device company, has announced the appointment of Dr. Scott MacDiarmid as their new Chief Medical Officer. With a dedicated mission to revolutionize the treatment of lower urinary tract symptoms (LUTS), Bright Uro aims to improve patient care through innovative urodynamic solutions.
Introducing Dr. Scott MacDiarmid
Dr. MacDiarmid is recognized as a prominent figure in the field of urology and urodynamics. He has made substantial contributions to the medical community with his authorship of influential texts, including "The Art of Voiding Dysfunction (LUTS): Diagnosis to Treatment Pathways" and co-authoring the highly regarded "Urodynamics Made Easy," now in its 4th edition. His expertise in diagnosing and treating voiding dysfunction is well established, as he leads the Alliance Urology Specialists Bladder Control Center and serves as an Adjunct Assistant Professor of Urology.
Vision for the Future
Expressing his enthusiasm for joining Bright Uro, Dr. MacDiarmid stated, "Bright Uro has made an exciting breakthrough in urodynamics, and I'm pleased to help bring it to the world. I am convinced the Glean™ Urodynamics System will advance the field and provide clinicians with diagnostic data they can trust and act upon to the benefit of their patients." His commitment will play a crucial role in educating healthcare professionals on the advantages of advanced urodynamic practices.
Commercial Leadership Team Announcement
In addition to Dr. MacDiarmid's appointment, Bright Uro has also unveiled its new commercial leadership team under Chief Commercial Officer Casey Kanel. This team consists of seasoned sales and marketing veterans, bringing a collective century of experience from industry leader Medtronic.
Profiles of Key Team Members
Leading this talented team is Kristen Comstock, Vice President of Marketing, who boasts over 20 years in the urology sector. Alongside her is Chris Runkle, Vice President of Sales, who has a remarkable 30-year record in establishing and managing successful sales teams across the nation.
Ben Abramowitz, the new West Regional Sales Director, comes with 25 years of expertise in urology and gynecology clinical sales. Furthermore, Jim Monacelli, North Regional Sales Director, adds his impressive 29 years of experience to the team, focusing on both sales training and medical education.
Preparing for an Exciting Launch
Chief Commercial Officer Casey Kanel expressed enthusiasm about the new appointments, remarking, "I'm delighted to have been able to recruit such accomplished and experienced sales and marketing leaders to prepare us for our 2025 launch of the Glean System. We now have all the pieces in place to execute the rollout of this revolutionary product and lay the groundwork for growing the company exponentially in the coming years." The strategic positioning of this team signals Bright Uro's commitment to fostering innovation and enhancing patient outcomes.
About Bright Uro
Located in California, Bright Uro is dedicated to transforming the understanding and treatment of lower urinary tract symptoms through cutting-edge technology. The flagship Glean™ Urodynamics System is innovatively designed to facilitate wireless, catheter-free urodynamics monitoring, aiming to enhance patient comfort and improve clinical results. More information can be found on their website.
Frequently Asked Questions
What is Bright Uro known for?
Bright Uro specializes in medical devices aimed at improving care for lower urinary tract symptoms with innovative technology.
Who is the new Chief Medical Officer?
Dr. Scott MacDiarmid has been appointed as the new Chief Medical Officer to lead Bright Uro's efforts in urodynamics.
What is the Glean™ Urodynamics System?
The Glean™ Urodynamics System is a novel device designed for wireless, catheter-free monitoring of urodynamic functions.
How experienced is the new commercial team?
The new commercial leadership team comprises professionals with over 100 years of combined experience from previous roles in leading industry companies.
What are Bright Uro's future plans?
Bright Uro is preparing to launch the Glean System in 2025, aiming to significantly enhance the landscape of urodynamic monitoring.
